Nivolumab for Resected Stage III or IV Melanoma at 9 Years
New England Journal of Medicine · 2026
DOI: 10.1056/nejmoa2504966 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, 2026. Verfasst von Paolo A Ascierto und 28 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy. Hauptthemen laut MEDLINE: Ipilimumab, Melanoma, Neoplasm Recurrence, Local, Nivolumab. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Bristol Myers Squibb.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy.
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
- Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Bergamo, Italy.
- National and Kapodistrian University of Athens, Athens.
- Hospital Clínic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona.
- Hospices Civils de Lyon, Pierre-Bénite, France.
ORCID-Profile: Paolo A Ascierto
Förderung
- Bristol Myers Squibb
Zitieren
APA
Ascierto, P. A., Del Vecchio, M., Merelli, B., Gogas, H., Arance, A. M., Dalle, S., Cowey, C. L., Schenker, M., Gaudy-Marqueste, C., Pigozzo, J., Márquez-Rodas, I., Butler, M. O., Di Giacomo, A. M., Gligich, O., De La Cruz-Merino, L., Arenberger, P., Atkinson, V., Nathan, P., Hill, A., …, & Larkin, J. (2026). Nivolumab for Resected Stage III or IV Melanoma at 9 Years. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2504966
Vancouver
Ascierto PA, Del Vecchio M, Merelli B, Gogas H, Arance AM, Dalle S, et al. Nivolumab for Resected Stage III or IV Melanoma at 9 Years. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2504966
BibTeX
@article{Ascierto2026,
author = {Ascierto, Paolo A and Del Vecchio, Michele and Merelli, Barbara and Gogas, Helen and Arance, Ana M and Dalle, Stéphane and Cowey, Charles Lance and Schenker, Michael and Gaudy-Marqueste, Caroline and Pigozzo, Jacopo and Márquez-Rodas, Iván and Butler, Marcus O and Di Giacomo, Anna Maria and Gligich, Oleg and De La Cruz-Merino, Luis and Arenberger, Petr and Atkinson, Victoria and Nathan, Paul and Hill, Andrew and Millward, Michael and Fecher, Leslie A and Khushalani, Nikhil I and Queirolo, Paola and Soomro, Raheela and Rathod, Dhanrajsinh and Askelson, Margarita and Pe Benito, Melanie and Joseph, Devanand and Larkin, James},
title = {Nivolumab for Resected Stage III or IV Melanoma at 9 Years},
journal = {New England Journal of Medicine},
year = {2026},
doi = {10.1056/nejmoa2504966}
}
EUVIMED